We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGOV
126
DELISTED
NIC Inc
EGOV
| $34.9M | 0.06% |
1,520,669
+204,177
| +16% | +$4.83M |
|
127
Booz Allen Hamilton
BAH
$9.15B
| $34.8M | 0.06% |
447,131
+22,212
| +5% | +$1.68M |
|
128
Texas Roadhouse
TXRH
$13.7B
| $34.6M | 0.06% |
658,564
+363,721
| +123% | +$17.7M |
|
129
Protolabs
PRLB
$2.13B
| $34.3M | 0.06% |
305,135
+26,303
| +9% | +$2.7M |
|
130
Pool Corp
POOL
$7.5B
| $34.2M | 0.05% |
125,908
-161,685
| -56% | -$37.4M |
|
131
Kratos Defense & Security Solutions
KTOS
$11.4B
| $33.9M | 0.05% |
2,168,495
+1,028,560
| +90% | +$16.5M |
|
132
FormFactor
FORM
$9.17B
| $33.8M | 0.05% |
1,153,347
+351,818
| +44% | +$8.68M |
|
133
PTC Therapeutics
PTCT
$6.12B
| $33.8M | 0.05% |
666,530
+227,379
| +52% | +$11.2M |
|
134
Inspire Medical Systems
INSP
$1.74B
| $33.8M | 0.05% |
388,190
+74,580
| +24% | +$5.73M |
|
|
YMAB
135
DELISTED
Y-mAbs Therapeutics
YMAB
| $33.4M | 0.05% |
773,987
+67,072
| +9% | +$2.54M |
|
|
BEAT
136
DELISTED
BioTelemetry, Inc.
BEAT
| $33.1M | 0.05% |
732,259
+63,469
| +9% | +$2.84M |
|
137
Varonis Systems
VRNS
$5B
| $32.8M | 0.05% |
1,111,485
+366,153
| +49% | +$9.16M |
|
138
Hamilton Lane
HLNE
$5.57B
| $32.5M | 0.05% |
482,287
+41,999
| +10% | +$2.64M |
|
|
AMK
139
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $32.4M | 0.05% |
1,188,619
+333,049
| +39% | +$8.16M |
|
140
AtriCure
ATRC
$2.11B
| $32.3M | 0.05% |
717,683
+62,279
| +10% | +$2.71M |
|
141
CBRE Group
CBRE
$42.9B
| $32.1M | 0.05% |
710,439
-2,962,282
| -81% | -$128M |
|
142
West Pharmaceutical
WST
$24.9B
| $31.8M | 0.05% |
139,817
+10,834
| +8% | +$2.13M |
|
143
EPAM Systems
EPAM
$5.03B
| $31.6M | 0.05% |
125,545
-12,374
| -9% | -$2.72M |
|
144
Baidu
BIDU
$37.2B
| $31.2M | 0.05% |
260,233
+65,392
| +34% | +$7M |
|
145
Helen of Troy
HELE
$693M
| $31.1M | 0.05% |
164,750
+6,652
| +4% | +$1.09M |
|
146
Silicon Motion
SIMO
$8.68B
| $31M | 0.05% |
634,991
+209,465
| +49% | +$9.28M |
|
147
MKS Inc
MKSI
$20.6B
| $30.7M | 0.05% |
271,313
+12,809
| +5% | +$1.27M |
|
148
Strategic Education
STRA
$1.92B
| $30.1M | 0.05% |
+196,005
| New | +$30.6M |
|
149
Ingersoll Rand
IR
$33.7B
| $30.1M | 0.05% |
1,069,060
+43,570
| +4% | +$1.23M |
|
150
Trip.com Group
TCOM
$29.1B
| $29.9M | 0.05% |
1,153,988
+494,902
| +75% | +$12.5M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.